Study Stopped
Sponsor/funding source decided to not move forward.
A Wearable EducAtional Intervention to REduce Angina
AWARE
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The AWARE-Angina study is a cluster randomized trial aimed at evaluating whether routine provider feedback of patients' angina burden and activity level can improve angina control. Patients will wear an activity monitor for 6 months, and their providers will be randomized to receive either monthly feedback or feedback at the end of the study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2017
CompletedFirst Posted
Study publicly available on registry
April 28, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedAugust 21, 2017
April 1, 2017
5 months
April 26, 2017
August 16, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Change in patients' mean daily number of steps
The investigator will plot step count for each patient over the study period and calculate a slope, representing change in number of steps per day enrolled in the study. The research team will calculate a mean slope for patients in each group (monthly feedback versus end-of-study period feedback) and compare between groups. 1. Number of steps will be measured continuously, and the team will evaluate the difference between baseline and 6 months
Baseline to 6 months
Secondary Outcomes (3)
Change in Distance Walked
Baseline to 6 months
Change in Angina Frequency
Baseline to 6 months
Change in Anti-Anginal Medication
Baseline to 6 months
Study Arms (2)
Monthly Feedback
EXPERIMENTALSites will receive monthly reports of their patients enrolled in the study with data for each of their patients participating in the study along with summary data for their practice and all patients participating in the study.
End-of-study Feedback
ACTIVE COMPARATORSites will only receive the report of their patients at the end of the 6 month follow-up period.
Interventions
Providers will receive monthly updates on step count and patient reported angina for each of their patients, with data derived from a wearable fitness tracker and every other week emailed surveys
Providers will receive an end-of-study update on step count and patient reported angina for each of their patients, with data derived from a wearable fitness tracker and every other week emailed surveys
Eligibility Criteria
You may qualify if:
- Acute MI within the prior 6 months
- At least one-vessel coronary artery disease (≥70% obstruction in any coronary artery or ≥50% in the left main coronary artery)
- English speaking
You may not qualify if:
- Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension)
- Non-ambulatory
- Anticipated life expectancy less than 6 months
- Does not own a smartphone operating the iOS or Android operating system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Gilead Sciencescollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2017
First Posted
April 28, 2017
Study Start
September 1, 2017
Primary Completion
February 1, 2018
Study Completion
July 1, 2018
Last Updated
August 21, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share